Tenaya Therapeutics, Inc. Employee Count
The employee counts Tenaya Therapeutics, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2023-12-31: Employees (as filed) 140; Filing 2024-03-18; Lease expense per employee $40,185.71.
- 2022-12-31: Employees (as filed) 141; Filing 2023-03-08; Lease expense per employee $41,666.67.
- 2021-12-31: Employees (as filed) 106; Filing 2022-03-23; Lease expense per employee $53,773.58.
- Available history
- 2021-12-31 to 2023-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2023-12-31 | 140 full-time | 2024-03-18 | $40,185.71 total lease cost |
| 2022-12-31 | 141 full-time | 2023-03-08 | $41,666.67 total lease cost |
| 2021-12-31 | 106 full-time | 2022-03-23 | $53,773.58 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |